がん診断におけるAI市場規模、成長と動向分析レポート 2025-2030年

この市場の成長は、世界的な医療IT支出の増加、医療従事者の不足、そして疾患の早期発見・分類に対する需要の高まりに起因しています。さらに、政府の取り組みの強化、スタートアップ企業や提携企業の増加、そしてベンチャーキャピタルからの資金提供の増加も相まって、市場の成長を支えています。がんの診断と治療は、過去10年間で大きく進歩しました。特に早期段階でのがん検出のための、技術的に高度なソリューションの利用増加が、市場の成長に貢献しています。

AI In Cancer Diagnostics Market Growth & Trends

The global AI in cancer diagnostics market size is estimated to reach USD 996.12 million by 2030, registering to grow at a CAGR of 24.12% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing need for lowering healthcare costs, the rising importance of big data in healthcare, improving adoption of precision medicine, and declining hardware costs are key factors driving the growth.

がん診断における世界のAI市場規模は、2030年までに9億9,612万米ドルに達すると予測されており、2025年から2030年にかけて24.12%のCAGRで成長する見込みです。医療費削減の必要性の高まり、医療におけるビッグデータの重要性の高まり、精密医療の導入促進、ハードウェアコストの低下が、成長を牽引する主な要因です。

The increasing scope of applications of artificial intelligence (AI) in various healthcare fields, including diagnostics; the rising prevalence of cancer; and the growing shortage of public health workforce are some of the key factors anticipated to fuel the adoption of artificial intelligence (AI) in cancer diagnostics over the forecast period. In addition, the increasing applicability of AI-based tools in cancer care and the rise in venture capital investments is further driving the surge in demand for this technology.

The presence of prominent players in the market such as Microsoft, Flatiron, Therapixel, and Tempus, is anticipated to positively impact the growth. These players are adopting strategies such as acquisitions, collaborations, expansions, and new product launches to increase the reach of their products in the industry and increase the availability of their products & services in diverse geographical areas. For instance, in December 2021, Microsoft announced a partnership with CVS Health to develop innovative solutions for patients to improve their health while empowering healthcare professionals with tools to better service patients.

Furthermore, the rising government support in the form of funding and initiatives for the development of healthcare infrastructure is anticipated to drive the demand for technologically advanced and cost-efficient devices over the forecast period.

AI In Cancer Diagnostics Market Report Scope

AI In Cancer Diagnostics Market Report Highlights

• Based on component, the software solutions segment dominated the market with a revenue share of 44.39% in 2024 and is expected to witness the fastest growth rate during the forecast period.

• Based on cancer type, breast cancer had a significant revenue share of 19.41% in 2024.

• Hospital segment dominated the market with the largest revenue share of 56.95% in 2024.

• North America AI in cancer diagnostics market dominated in 2023 with the largest share of 54.74%.

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.1.1. Component

1.1.2. Cancer type

1.1.3. End use

1.1.4. Regional scope

1.1.5. Estimates and forecast timeline.

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased database.

1.3.2. GVR’s internal database

1.3.3. Secondary sources

1.3.4. Primary research

1.3.5. Details of primary research

1.4. Information or Data Analysis

1.4.1. Data analysis models

1.5. Market Formulation & Validation

1.6. Model Details

1.6.1. Commodity flow analysis (Model 1)

1.7. List of Secondary Sources

1.8. List of Primary Sources

1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Component outlook

2.2.2. Cancer type outlook

2.2.3. End use outlook

2.2.4. Regional outlook

2.3. Competitive Insights

Chapter 3. Artificial Intelligence In Cancer Diagnostics Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.2. Market restraint analysis

3.2.3. Market opportunity analysis

3.2.4. Market challenges analysis

3.3. Artificial Intelligence In Cancer Diagnostics Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Supplier power

3.3.1.2. Buyer power

3.3.1.3. Substitution threat

3.3.1.4. Threat of new entrant

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Economic landscape

3.3.2.3. Social landscape

3.3.2.4. Technological landscape

3.3.2.5. Environmental landscape

3.3.2.6. Legal landscape

3.4. COVID-19 Impact

3.5. Case Study

Chapter 4. Artificial Intelligence In Cancer Diagnostics Market: Component Estimates & Trend Analysis

4.1. Component Market Share, 2024 & 2030

4.2. Segment Dashboard

4.3. Global Artificial Intelligence In Cancer Diagnostics Market by Component Outlook

4.4. Software Solutions

4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

4.5. Hardware

4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

4.6. Services

4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Artificial Intelligence In Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis

5.1. Cancer Type Market Share, 2024 & 2030

5.2. Segment Dashboard

5.3. Global Artificial Intelligence In Cancer Diagnostics Market by Cancer Type Outlook

5.4. Breast Cancer

5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.5. Lung Cancer

5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.6. Prostate Cancer

5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.7. Colorectal Cancer

5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.8. Brain Tumor

5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.9. Others

5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Artificial Intelligence In Cancer Diagnostics Market: End Use Estimates & Trend Analysis

6.1. End Use Market Share, 2023 & 2030

6.2. Segment Dashboard

6.3. Global Artificial Intelligence In Cancer Diagnostics Market by End Use Outlook

6.4. Hospital

6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.5. Surgical Centers and Medical Institutes

6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.6. Others

6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Artificial Intelligence In Cancer Diagnostics Market: Regional Estimates & Trend Analysis, By Component, By Cancer Type, By End Use

7.1. Regional Market Share Analysis, 2024 & 2030

7.2. Regional Market Dashboard

7.3. Global Regional Market Snapshot

7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:

7.5. North America

7.5.1. U.S.

7.5.1.1. Key country dynamics

7.5.1.2. Regulatory framework

7.5.1.3. Competitive scenario

7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)

7.5.2. Canada

7.5.2.1. Key country dynamics

7.5.2.2. Regulatory framework

7.5.2.3. Competitive scenario

7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)

7.5.3. Mexico

7.5.3.1. Key country dynamics

7.5.3.2. Regulatory framework

7.5.3.3. Competitive scenario

7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

7.6. Europe

7.6.1. UK

7.6.1.1. Key country dynamics

7.6.1.2. Regulatory framework

7.6.1.3. Competitive scenario

7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)

7.6.2. Germany

7.6.2.1. Key country dynamics

7.6.2.2. Regulatory framework

7.6.2.3. Competitive scenario

7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)

7.6.3. France

7.6.3.1. Key country dynamics

7.6.3.2. Regulatory framework

7.6.3.3. Competitive scenario

7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)

7.6.4. Italy

7.6.4.1. Key country dynamics

7.6.4.2. Regulatory framework

7.6.4.3. Competitive scenario

7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)

7.6.5. Spain

7.6.5.1. Key country dynamics

7.6.5.2. Regulatory framework

7.6.5.3. Competitive scenario

7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)

7.6.6. Norway

7.6.6.1. Key country dynamics

7.6.6.2. Regulatory framework

7.6.6.3. Competitive scenario

7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)

7.6.7. Sweden

7.6.7.1. Key country dynamics

7.6.7.2. Regulatory framework

7.6.7.3. Competitive scenario

7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)

7.6.8. Denmark

7.6.8.1. Key country dynamics

7.6.8.2. Regulatory framework

7.6.8.3. Competitive scenario

7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)

7.7. Asia Pacific

7.7.1. Japan

7.7.1.1. Key country dynamics

7.7.1.2. Regulatory framework

7.7.1.3. Competitive scenario

7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)

7.7.2. China

7.7.2.1. Key country dynamics

7.7.2.2. Regulatory framework

7.7.2.3. Competitive scenario

7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)

7.7.3. India

7.7.3.1. Key country dynamics

7.7.3.2. Regulatory framework

7.7.3.3. Competitive scenario

7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)

7.7.4. Australia

7.7.4.1. Key country dynamics

7.7.4.2. Regulatory framework

7.7.4.3. Competitive scenario

7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)

7.7.5. South Korea

7.7.5.1. Key country dynamics

7.7.5.2. Regulatory framework

7.7.5.3. Competitive scenario

7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)

7.7.6. Thailand

7.7.6.1. Key country dynamics

7.7.6.2. Regulatory framework

7.7.6.3. Competitive scenario

7.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)

7.8. Latin America

7.8.1. Brazil

7.8.1.1. Key country dynamics

7.8.1.2. Regulatory framework

7.8.1.3. Competitive scenario

7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)

7.8.2. Argentina

7.8.2.1. Key country dynamics

7.8.2.2. Regulatory framework

7.8.2.3. Competitive scenario

7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)

7.9. MEA

7.9.1. South Africa

7.9.1.1. Key country dynamics

7.9.1.2. Regulatory framework

7.9.1.3. Competitive scenario

7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)

7.9.2. Saudi Arabia

7.9.2.1. Key country dynamics

7.9.2.2. Regulatory framework

7.9.2.3. Competitive scenario

7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)

7.9.3. UAE

7.9.3.1. Key country dynamics

7.9.3.2. Regulatory framework

7.9.3.3. Competitive scenario

7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)

7.9.4. Kuwait

7.9.4.1. Key country dynamics

7.9.4.2. Regulatory framework

7.9.4.3. Competitive scenario

7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants

8.2. Company/Competition Categorization

8.3. Innovators

8.4. Vendor Landscape

8.4.1. EarlySign

8.4.1.1. Company overview

8.4.1.2. Financial performance

8.4.1.3. Technology Type benchmarking

8.4.1.4. Strategic initiatives

8.4.2. Cancer Center.ai

8.4.2.1. Company overview

8.4.2.2. Financial performance

8.4.2.3. Technology Type benchmarking

8.4.2.4. Strategic initiatives

8.4.3. Microsoft

8.4.3.1. Company overview

8.4.3.2. Financial performance

8.4.3.3. Technology Type benchmarking

8.4.3.4. Strategic initiatives

8.4.4. FLATIRON HEALTH

8.4.4.1. Company overview

8.4.4.2. Financial performance

8.4.4.3. Technology Type benchmarking

8.4.4.4. Strategic initiatives

8.4.5. PathAI, Inc.

8.4.5.1. Company overview

8.4.5.2. Financial performance

8.4.5.3. Technology Type benchmarking

8.4.5.4. Strategic initiatives

8.4.6. Therapixel

8.4.6.1. Company overview

8.4.6.2. Financial performance

8.4.6.3. Technology Type benchmarking

8.4.6.4. Strategic initiatives

8.4.7. Tempus AI, Inc.

8.4.7.1. Company overview

8.4.7.2. Financial performance

8.4.7.3. Technology Type benchmarking

8.4.7.4. Strategic initiatives

8.4.8. Paige AI Inc.

8.4.8.1. Company overview

8.4.8.2. Financial performance

8.4.8.3. Technology Type benchmarking

8.4.8.4. Strategic initiatives

8.4.9. Kheiron Medical Technologies Limited

8.4.9.1. Company overview

8.4.9.2. Financial performance

8.4.9.3. Technology Type benchmarking

8.4.9.4. Strategic initiatives

8.4.10. SkinVision

8.4.10.1. Company overview

8.4.10.2. Financial performance

8.4.10.3. Technology Type benchmarking

8.4.10.4. Strategic initiatives

List of Tables

Table 1. List of secondary sources

Table 2. List of abbreviations

Table 3. Global AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 4. Global AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 5. Global AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 6. North America AI in cancer diagnostics market, by country, 2018 – 2030 (USD Million)

Table 7. North America AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 8. North America AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 9. North America AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 10. U.S. AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 11. U.S. AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 12. U.S. AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 13. Canada AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 14. Canada AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 15. Canada AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 16. Mexico AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 17. Mexico AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 18. Mexico AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 19. Europe AI in cancer diagnostics market, by country, 2018 – 2030 (USD Million)

Table 20. Europe AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 21. Europe AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 22. Europe AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 23. UK AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 24. UK AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 25. UK AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 26. Germany AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 27. Germany AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 28. Germany AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 29. France AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 30. France AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 31. France AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 32. Italy AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 33. Italy AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 34. Italy AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 35. Spain AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 36. Spain AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 37. Spain AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 38. Norway AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 39. Norway AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 40. Norway AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 41. Denmark AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 42. Denmark AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 43. Denmark AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 44. Sweden AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 45. Sweden AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 46. Sweden AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 47. Asia Pacific AI in cancer diagnostics market, by country, 2018 – 2030 (USD Million)

Table 48. Asia Pacific AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 49. Asia Pacific AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 50. Asia Pacific AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 51. Japan AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 52. Japan AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 53. Japan AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 54. China AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 55. China AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 56. China AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 57. India AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 58. India AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 59. India AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 60. Australia AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 61. Australia AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 62. Australia AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 63. South Korea AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 64. South Korea AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 65. South Korea AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 66. Thiland AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 67. Thailand AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 68. Thailand AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 69. Latin America AI in cancer diagnostics market, by country, 2018 – 2030 (USD Million)

Table 70. Latin America AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 71. Latin America AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 72. Latin America AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 73. Brazil AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 74. Brazil AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 75. Brazil AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 76. Argentina AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 77. Argentina AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 78. Argentina AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 79. Middle East & Africa AI in cancer diagnostics market, by country, 2018 – 2030 (USD Million)

Table 80. Middle East & Africa AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 81. Middle East & Africa AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 82. Middle East & Africa AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 83. South Africa AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 84. South Africa AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 85. South Africa AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 86. Saudi Arabia AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 87. Saudi Arabia AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 88. Saudi Arabia AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 89. UAE AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 90. UAE AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 91. UAE AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

Table 92. Kuwait AI in cancer diagnostics market, by component, 2018 – 2030 (USD Million)

Table 93. Kuwait AI in cancer diagnostics market, by cancer type, 2018 – 2030 (USD Million)

Table 94. Kuwait AI in cancer diagnostics market, by end use, 2018 – 2030 (USD Million)

List of Figures

Fig. 1 Market research process

Fig. 2 Information procurement

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value chain-based sizing & forecasting

Fig. 6 Market formulation & validation

Fig. 7 Market segmentation

Fig. 8 Market snapshot

Fig. 9 Segment snapshot

Fig. 10 Competitive landscape snapshot

Fig. 11 Market trends & outlook

Fig. 12 PESTLE analysis

Fig. 13 Porter’s five forces analysis

Fig. 14 AI in cancer diagnostics market: Component outlook and key takeaways

Fig. 15 AI in cancer diagnostics market: Component movement analysis

Fig. 16 Software solutions market, 2018 – 2030 (USD Million)

Fig. 17 Hardware market, 2018 – 2030 (USD Million)

Fig. 18 Services market, 2018 – 2030 (USD Million)

Fig. 19 AI in cancer diagnostics market: Cancer type outlook and key takeaways

Fig. 20 AI in cancer diagnostics market: Cancer type movement analysis

Fig. 21 Breast cancer market, 2018 – 2030 (USD Million)

Fig. 22 Lung cancer market, 2018 – 2030 (USD Million)

Fig. 23 Prostate cancer market, 2018 – 2030 (USD Million)

Fig. 24 Colorectal cancer market, 2018 – 2030 (USD Million)

Fig. 25 Brain Tumor market, 2018 – 2030 (USD Million)

Fig. 26 Others market, 2018 – 2030 (USD Million)

Fig. 27 AI in cancer diagnostics market: End use outlook and key takeaways

Fig. 28 AI in cancer diagnostics market: End use movement analysis

Fig. 29 Hospitals market, 2018 – 2030 (USD Million)

Fig. 30 Surgical centers and medical institutes market, 2018 – 2030 (USD Million)

Fig. 31 Others market, 2018 – 2030 (USD Million)

Fig. 32 Regional marketplace: Key takeaways

Fig. 33 Regional outlook, 2024 & 2030

Fig. 34 AI in cancer diagnostics market: Region movement analysis

Fig. 35 North America AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 36 US AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 37 Key country dynamics

Fig. 38 Canada AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 39 Key country dynamics

Fig. 40 Mexico AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 41 Key country dynamics

Fig. 42 Europe AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 43 UK AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 44 Key country dynamics

Fig. 45 Germany AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 46 Key country dynamics

Fig. 47 France AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 48 Key country dynamics

Fig. 49 Italy AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 50 Key country dynamics

Fig. 51 Spain AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 52 Key country dynamics

Fig. 53 Spain AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 54 Key country dynamics

Fig. 55 Norway AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 56 Key country dynamics

Fig. 57 Denmark AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 58 Key country dynamics

Fig. 59 Sweden AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 60 Key country dynamics

Fig. 61 Asia Pacific AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 62 Japan AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 63 Key country dynamics

Fig. 64 China AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 65 Key country dynamics

Fig. 66 India AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 67 Key country dynamics

Fig. 68 Australia AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 69 Key country dynamics

Fig. 70 South Korea AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 71 Key country dynamics

Fig. 72 Thailand AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 73 Key country dynamics

Fig. 74 Latin America AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 75 Brazil AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 76 Key country dynamics

Fig. 77 Argentina AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 78 Key country dynamics

Fig. 79 Middle East and Africa AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 80 South Africa AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 81 Key country dynamics

Fig. 82 Saudi Arabia AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 83 Key country dynamics

Fig. 84 UAE AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 85 Key country dynamics

Fig. 86 Kuwait AI in cancer diagnostics market, 2018 – 2030 (USD Million)

Fig. 87 Key country dynamics

Fig. 88 Company categorization

Fig. 89 Strategy mapping

Fig. 90 Company market position analysis

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• ARクラウド市場規模、成長と動向分析レポート 2025-2033年
• ノーコードAIプラットフォーム市場規模、成長と動向分析レポート 2025-2033年
• 量子コンピューティングにおけるAI最適化市場規模、成長と動向分析レポート 2025-2033年
• ワイヤレス状態監視システム市場規模、成長と動向分析レポート 2025-2033年
• ゲームストリーミング市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧